+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Nitinol Revascularization Device Market - Global Forecast 2026-2032- Product Image
Nitinol Revascularization Device Market - Global Forecast 2026-2032- Product Image
Sale

Nitinol Revascularization Device Market - Global Forecast 2026-2032

  • Report

  • 189 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6117799
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Nitinol Revascularization Device Market is projected to reach USD 2.26 Billion in 2026. It is expected to continue growing at a CAGR of 11.01%, reaching USD 4.25 Billion by 2032.

Nitinol Revascularization Devices: Executive Overview

Nitinol revascularization devices use nickel-titanium’s shape-memory and superelastic properties to support minimally invasive treatment of narrowed or obstructed blood vessels. Their clinical relevance is tied to challenging anatomy, deployment precision, radial support, flexibility, and resistance to vessel deformation. Adoption depends on evidence of safety and effectiveness, physician familiarity, reimbursement, hospital procurement practices, and regulatory requirements across vascular care settings.

How Clinical and Regulatory Priorities Are Reshaping Revascularization

The landscape is shifting toward less invasive procedures, more durable lesion treatment, and greater attention to patient selection and long-term follow-up. Device development increasingly emphasizes deliverability, controlled expansion, fracture resistance, visibility, thrombosis management, and compatibility with adjunctive therapies. Regulatory and clinical stakeholders are also placing greater weight on comparative evidence, post-market surveillance, standardized endpoints, and outcomes that reflect quality of life as well as procedural success.

Artificial Intelligence’s Cumulative Role Across the Device Lifecycle

Artificial intelligence is contributing to vascular imaging interpretation, lesion assessment, procedural planning, navigation support, and outcome monitoring. Machine-learning systems can help identify stenosis patterns, estimate anatomical complexity, and organize longitudinal clinical data, although performance depends on representative datasets, image quality, workflow integration, and clinician oversight. For manufacturers and providers, responsible use requires validation, cybersecurity controls, explainability appropriate to the clinical task, and clear accountability when algorithmic recommendations influence treatment decisions.

Regional Insights Across the Global Revascularization Landscape

North America is characterized by advanced interventional infrastructure, established reimbursement pathways, and strong emphasis on clinical evidence and post-market monitoring. Europe combines sophisticated vascular care with country-level variation in procurement, reimbursement, and health-technology assessment. Asia-Pacific presents diverse regulatory and hospital environments, with demand shaped by expanding specialist capacity and differences in access between major cities and underserved areas. Latin America’s adoption is influenced by economic conditions, import requirements, specialist availability, and public-private care structures. The Middle East is supported by investment in tertiary hospitals and medical technology, while procurement and reimbursement vary across states. Africa remains highly heterogeneous, with adoption constrained in many settings by limited catheterization capacity, specialist shortages, supply continuity, and affordability.

Group-Level Patterns Across ASEAN, BRICS, the EU, G7, GCC, and NATO

ASEAN markets reflect uneven healthcare infrastructure, regulatory maturity, and access to interventional specialists, making training and distribution resilience important. BRICS members span large and diverse patient populations but differ substantially in domestic manufacturing, reimbursement, and public procurement. The European Union benefits from shared regulatory principles while retaining national differences in purchasing and coverage. G7 countries generally combine mature clinical systems with demanding evidence, safety, and value requirements. GCC states often concentrate advanced care in major urban hospitals and pursue technology-enabled clinical capacity. NATO members are not a uniform healthcare bloc, but many share priorities around supply-chain resilience, emergency preparedness, and secure medical technology infrastructure.

Country-Level Considerations for Adoption and Access

Australia’s geographically dispersed care system heightens the importance of referral networks and specialist access. Brazil and Mexico must navigate regional inequalities, public-private differences, and procurement complexity. Canada and the United States have advanced vascular services but distinct reimbursement, purchasing, and regulatory pathways. China and India combine substantial clinical need with varied hospital capabilities and evolving domestic device ecosystems. France, Germany, Italy, Spain, and the United Kingdom operate within mature European clinical environments, while reimbursement, assessment, and procurement remain nationally differentiated. Japan emphasizes careful clinical evaluation and established hospital workflows. South Korea combines sophisticated tertiary care with active technology adoption. Russia’s access is shaped by regulatory, procurement, and supply-chain conditions, while local availability can vary considerably across institutions.

Actions for Leaders: Build Evidence, Resilience, and Clinician-Centered Value

Industry leaders should prioritize robust evidence that connects device performance with meaningful patient outcomes, including durability, reintervention, complications, and quality of life. Product strategy should address anatomy-specific needs while simplifying delivery, imaging, training, and workflow integration. Organizations should strengthen regulatory intelligence, local clinical partnerships, and post-market data collection across diverse populations. Supply-chain planning should include qualified alternatives, inventory visibility, and regionally appropriate service models. AI-enabled tools should be introduced through clinically validated workflows with human oversight, cybersecurity protections, and transparent performance monitoring. Finally, value communication should address hospitals, clinicians, payers, and patients rather than relying solely on technical specifications.

Research Methodology for the Nitinol Revascularization Device Assessment

This executive summary applies a structured, evidence-led review of the nitinol revascularization device landscape. The assessment considers device engineering, clinical use, procedural trends, regulatory expectations, reimbursement and procurement conditions, healthcare infrastructure, regional access, and the potential role of artificial intelligence. Geographic interpretation incorporates North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, alongside the specified country and group lenses. Findings are framed qualitatively and avoid unsupported market estimates, forecasts, market shares, or company-specific claims. Conclusions should be interpreted alongside current clinical guidelines, applicable regulatory documents, peer-reviewed evidence, and local health-system requirements.

Conclusion: Competing Through Clinical Confidence and Practical Access

Nitinol revascularization devices are positioned within a broader transition toward precise, minimally invasive vascular care. Success will depend not only on material performance, but also on durable clinical evidence, dependable delivery systems, appropriate patient selection, trained teams, and equitable access. Regional and country differences make adaptable regulatory, reimbursement, training, and service strategies essential. Leaders that combine validated innovation with transparent outcomes, resilient operations, and responsible digital integration will be better placed to support clinicians and patients across diverse healthcare environments.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Nitinol Revascularization Device Market, by Product Type
7.1. Introduction
7.2. Balloon Expandable Stent
7.2.1. Coronary Stent
7.2.2. Peripheral Stent
7.3. Self Expanding Nitinol Stent
7.3.1. Neurovascular Stent
7.3.2. Peripheral Stent
8. Nitinol Revascularization Device Market, by Application
8.1. Introduction
8.2. Coronary Artery Disease
8.3. Neurovascular
8.4. Peripheral Artery Disease
8.4.1. Below The Knee
8.4.2. Femoropopliteal
8.4.3. Iliofemoral
9. Nitinol Revascularization Device Market, by End User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Hospitals
9.4. Specialty Clinics
10. Nitinol Revascularization Device Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. North America
10.4. Latin America
10.5. Europe
10.6. Middle East
10.7. Africa
11. Nitinol Revascularization Device Market, by Group
11.1. Introduction
11.2. ASEAN
11.3. GCC
11.4. European Union
11.5. BRICS
11.6. G7
11.7. NATO
12. Nitinol Revascularization Device Market, by Country
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. United Kingdom
12.7. Germany
12.8. France
12.9. Russia
12.10. Italy
12.11. Spain
12.12. China
12.13. India
12.14. Japan
12.15. Australia
12.16. South Korea
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Abbott Laboratories
14.2. Admedes Schuessler GmbH
14.3. AngioDynamics, Inc.
14.4. Becton, Dickinson and Company
14.5. Bentley InnoMed GmbH
14.6. Biotronik SE & Co. KG
14.7. Boston Scientific Corporation
14.8. C. R. Bard, Inc.
14.9. Cook Medical LLC
14.10. Edwards Lifesciences Corporation
14.11. Elixir Medical Corporation
14.12. ELLA-CS
14.13. Endologix, Inc.
14.14. Johnson & Johnson
14.15. JOTEC GmbH
14.16. Lombard Medical, Inc.
14.17. Medtronic plc
14.18. Merit Medical Systems, Inc.
14.19. MicroPort NeuroTech
14.20. Nipro Corporation
14.21. Penumbra, Inc.
14.22. Stryker Corporation
14.23. Terumo Corporation
14.24. W. L. Gore & Associates, Inc.
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Nitinol Revascularization Device Market, Years Considered for the Study
FIGURE 2. Global Nitinol Revascularization Device Market, Research Design
FIGURE 3. Global Nitinol Revascularization Device Market, Research Framework
FIGURE 4. Global Nitinol Revascularization Device Market, Data Triangulation
FIGURE 5. Global Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Nitinol Revascularization Device Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 7. Global Nitinol Revascularization Device Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Nitinol Revascularization Device Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Nitinol Revascularization Device Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Nitinol Revascularization Device Market Size, by End User, 2025 vs 2032 (%)
FIGURE 11. Global Nitinol Revascularization Device Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Nitinol Revascularization Device Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Nitinol Revascularization Device Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Nitinol Revascularization Device Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Nitinol Revascularization Device Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Nitinol Revascularization Device Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Nitinol Revascularization Device Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Nitinol Revascularization Device Market Segmentation & Coverage
TABLE 2. Global Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 3. Global Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 4. Global Balloon Expandable Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Balloon Expandable Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Balloon Expandable Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Coronary Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Coronary Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Coronary Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Peripheral Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Peripheral Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Peripheral Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Self Expanding Nitinol Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Self Expanding Nitinol Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Self Expanding Nitinol Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Neurovascular Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Neurovascular Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Neurovascular Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Peripheral Stent Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Peripheral Stent Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Peripheral Stent Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 23. Global Coronary Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Coronary Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Coronary Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Neurovascular Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Neurovascular Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Neurovascular Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Peripheral Artery Disease Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Peripheral Artery Disease Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Peripheral Artery Disease Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Below The Knee Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Below The Knee Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Below The Knee Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Femoropopliteal Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Femoropopliteal Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Femoropopliteal Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Iliofemoral Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Iliofemoral Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Iliofemoral Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 42. Global Ambulatory Surgical Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Ambulatory Surgical Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Ambulatory Surgical Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Specialty Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 49. Global Specialty Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 50. Global Specialty Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 51. Global Nitinol Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Asia-Pacific Nitinol Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Asia-Pacific Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 54. Asia-Pacific Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 55. Asia-Pacific Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 56. Asia-Pacific Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Asia-Pacific Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 58. Asia-Pacific Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. North America Nitinol Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. North America Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 61. North America Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 62. North America Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 63. North America Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 64. North America Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 65. North America Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 66. Latin America Nitinol Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Latin America Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 68. Latin America Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 69. Latin America Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 70. Latin America Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 71. Latin America Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 72. Latin America Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 73. Europe Nitinol Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 74. Europe Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 75. Europe Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 76. Europe Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 77. Europe Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 78. Europe Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 79. Europe Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 80. Middle East Nitinol Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Middle East Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 82. Middle East Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 83. Middle East Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 84. Middle East Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. Middle East Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 86. Middle East Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 87. Africa Nitinol Revascularization Device Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Africa Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 89. Africa Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 90. Africa Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 91. Africa Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Africa Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 93. Africa Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 94. Global Nitinol Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. ASEAN Nitinol Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. ASEAN Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 97. ASEAN Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 98. ASEAN Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 99. ASEAN Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 100. ASEAN Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 101. ASEAN Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 102. GCC Nitinol Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. GCC Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 104. GCC Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 105. GCC Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 106. GCC Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 107. GCC Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 108. GCC Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 109. European Union Nitinol Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. European Union Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 111. European Union Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 112. European Union Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 113. European Union Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 114. European Union Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 115. European Union Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 116. BRICS Nitinol Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. BRICS Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 118. BRICS Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 119. BRICS Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 120. BRICS Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. BRICS Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 122. BRICS Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. G7 Nitinol Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. G7 Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 125. G7 Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 126. G7 Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 127. G7 Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. G7 Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 129. G7 Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 130. NATO Nitinol Revascularization Device Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. NATO Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 132. NATO Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 133. NATO Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 134. NATO Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. NATO Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 136. NATO Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 137. Global Nitinol Revascularization Device Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. United States Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 139. United States Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 140. United States Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 141. United States Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 142. United States Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. United States Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 144. United States Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Canada Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 146. Canada Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 147. Canada Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 148. Canada Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 149. Canada Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 150. Canada Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 151. Canada Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 152. Mexico Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 153. Mexico Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 154. Mexico Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 155. Mexico Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 156. Mexico Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 157. Mexico Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 158. Mexico Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 159. Brazil Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 160. Brazil Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 161. Brazil Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 162. Brazil Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 163. Brazil Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. Brazil Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 165. Brazil Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. United Kingdom Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 167. United Kingdom Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 168. United Kingdom Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 169. United Kingdom Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 170. United Kingdom Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. United Kingdom Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 172. United Kingdom Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Germany Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 174. Germany Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 175. Germany Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 176. Germany Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 177. Germany Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. Germany Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 179. Germany Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 180. France Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 181. France Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 182. France Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 183. France Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 184. France Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. France Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 186. France Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 187. Russia Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 188. Russia Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 189. Russia Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 190. Russia Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 191. Russia Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. Russia Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 193. Russia Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 194. Italy Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 195. Italy Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 196. Italy Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 197. Italy Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 198. Italy Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Italy Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 200. Italy Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. Spain Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 202. Spain Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 203. Spain Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 204. Spain Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 205. Spain Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. Spain Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 207. Spain Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 208. China Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 209. China Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 210. China Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 211. China Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 212. China Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. China Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 214. China Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 215. India Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 216. India Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 217. India Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 218. India Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 219. India Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. India Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 221. India Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Japan Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 223. Japan Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 224. Japan Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 225. Japan Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 226. Japan Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Japan Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 228. Japan Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 229. Australia Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 230. Australia Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 231. Australia Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 232. Australia Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 233. Australia Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. Australia Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 235. Australia Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. South Korea Nitinol Revascularization Device Market Size, 2017-2032 (USD Million)
TABLE 237. South Korea Nitinol Revascularization Device Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 238. South Korea Nitinol Revascularization Device Market Size, by Balloon Expandable Stent, 2017-2032 (USD Million)
TABLE 239. South Korea Nitinol Revascularization Device Market Size, by Self Expanding Nitinol Stent, 2017-2032 (USD Million)
TABLE 240. South Korea Nitinol Revascularization Device Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. South Korea Nitinol Revascularization Device Market Size, by Peripheral Artery Disease, 2017-2032 (USD Million)
TABLE 242. South Korea Nitinol Revascularization Device Market Size, by End User, 2017-2032 (USD Million)
TABLE 243. Global Nitinol Revascularization Device Market Share, by Key Player, 2025
TABLE 244. Global Nitinol Revascularization Device Market, Key Experts

Companies Mentioned

  • Abbott Laboratories
  • Admedes Schuessler GmbH
  • AngioDynamics, Inc.
  • Becton, Dickinson and Company
  • Bentley InnoMed GmbH
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Elixir Medical Corporation
  • ELLA-CS
  • Endologix, Inc.
  • Johnson & Johnson
  • JOTEC GmbH
  • Lombard Medical, Inc.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • MicroPort NeuroTech
  • Nipro Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

Related Topics

Related Reports

Peripheral Vascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Peripheral Vascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 185 Pages
  • Global
From
Revascularization Device Market - Global Forecast 2026-2032 - Product Image

Revascularization Device Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Cardiovascular Repair & Reconstruction Devices Market - Global Forecast 2026-2032 - Product Image

Cardiovascular Repair & Reconstruction Devices Market - Global Forecast 2026-2032

  • Report
  • 196 Pages
  • Global
From
Coronary Artery Bypass Device Market: Industry Trends, Innovations, and Forecast to 2031 - Product Image

Coronary Artery Bypass Device Market: Industry Trends, Innovations, and Forecast to 2031

  • Report
  • 171 Pages
  • Global
From
Transcatheter Pulmonary Valve Market Analysis: Clinical Trends, Technological Segmentation, and Strategic Landscape (2026-2031) - Product Image

Transcatheter Pulmonary Valve Market Analysis: Clinical Trends, Technological Segmentation, and Strategic Landscape (2026-2031)

  • Report
  • 128 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.